Stockholm, 11 May 2023 Virtune, the first regulated digital asset manager in Sweden to launch…
Toronto, Ontario–(Newsfile Corp. – May 11, 2023) – SuperBuzz Inc. (TSXV: SPZ) (“SuperBuzz” or the…
Publication recognizes them for their creativity, strategic thinking, and leadership in the development and execution…
JAKARTA, May 12, 2023 – (ACN Newswire) – PT PLN (Persero) shows its readiness to…
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101…
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101…
Data Will Also Be Presented in a Poster Session at the American Society of Clinical…
Data Will Also Be Presented in a Poster Session at the American Society of Clinical…
Updated Clinical Data from the Ongoing Phase 1b Dose-Escalation Study of RVU120 in Patients with AML…
Updated Clinical Data from the Ongoing Phase 1b Dose-Escalation Study of RVU120 in Patients with AML…
MENDUS TO PRESENT UPDATES ON IMMUNOMONITORING DATA FROM ADVANCE II TRIAL AND PROGRESS ON THE…
MENDUS TO PRESENT UPDATES ON IMMUNOMONITORING DATA FROM ADVANCE II TRIAL AND PROGRESS ON THE…
Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc….
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
WATERTOWN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
WATERTOWN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF APRIL 2023 VANCOUVER, BC, CANADA, May 11,…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF APRIL 2023 VANCOUVER, BC, CANADA, May 11,…